Recruiting Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer NCT06719700 Conditions Bronchial Neoplasms, Carcinoma, Bronchogenic, Chemoradiotherapy, +11 more Locations Sun yat-sen University Cancer Center — Guangzhou, Guangdong, China View Trial Details
Recruiting Surufatinib in Combination With Neoadjuvant Chemo-immunotherapy and Concurrent Chemoradiotherapy for Patients With Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma NCT07086469 Conditions Carcinoma, Carcinoma, Squamous Cell, Chemoradiotherapy, +16 more Locations Sun yat-sen University Cancer Center — Guangzhou, Guangdong, China View Trial Details
Recruiting Combination of Concurrent Chemoradiotherapy With Surufatinib and Tislelizumab in Patients With Locally Advanced Non-Small Cell Lung Cancer NCT07086456 Conditions Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more Locations Sun yat-sen University Cancer Center — Guangzhou, Guangdong, China View Trial Details
